Press Releases

Date	Title and Summary	Additional Formats
Toggle Summary Apr 26, 2010	EDAP Outlines U.S. ENLIGHT Clinical Strategy Ablatherm HIFU Trial Update: IDE Submission Expected in 2012	View HTML EDAP Outlines U.S. ENLIGHT Clinical Strategy 15.1 KB
Toggle Summary Apr 22, 2010	EDAP Highlights Ablatherm-HIFU and Sonolith i-move at European Association of Urology Conference Launches Sonolith i-move Lithotripsy Device Ablatherm-HIFU Featured as Superior Technology	View HTML EDAP Highlights Ablatherm-HIFU and Sonolith i-move at European Association of Urology Conference 15.8 KB
Toggle Summary Apr 12, 2010	EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device Official Marketing Launch at European Association Urology Congress, Barcelona	View HTML EDAP Receives European Approval for New Sonolith i-move Lithotripsy Device 15 KB
Toggle Summary Mar 30, 2010	EDAP Reports Record Full Year 2009 Financial Results 2009 Full Year Highlights: , Mar 30, 2010 (GlobeNewswire via COMTEX News Network) -- Record revenue for the third consecutive year: EUR 24.9 million (USD 34.7 million), up 7.9% -- Gross margin increased to a five year high 43.0% compared to prior year 39.8% -- Strong cash position of EUR 12.7	View HTML EDAP Reports Record Full Year 2009 Financial Results 28.7 KB
Toggle Summary Mar 22, 2010	EDAP Ablatherm(R)-HIFU Nominated for European Inventor Award 2010 LYON, France, Mar 22, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, reported today that the INSERM team and Emmanuel Blanc, the Company's Chief Technology Officer, have been nominated for the European Inventor Award 2010.	View HTML EDAP Ablatherm(R)-HIFU Nominated for European Inventor Award 2010 14.7 KB
Toggle Summary Mar 10, 2010	EDAP Announces Webcast and Conference Call of Fourth Quarter and Full Year 2009 Results LYON, France, Mar 10, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced today details relating to its fourth quarter and full year 2009 results announcement, which will take place on Tuesday, March 30, 2010, before the	View HTML EDAP Announces Webcast and Conference Call of Fourth Quarter and Full Year 2009 Results 13.3 KB
Toggle Summary Mar 09, 2010	EDAP Receives Japanese Approval for Sonolith I-Sys Enters Largest Global Lithotripsy Market	View HTML EDAP Receives Japanese Approval for Sonolith I-Sys 15.2 KB
Toggle Summary Mar 05, 2010	EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium Session Emphasizes Attractiveness of Ablatherm-HIFU in Focal Therapy	View HTML EDAP Presents Ablatherm-HIFU Data in Localized Prostate Cancer at Third Focal Therapy Symposium 15.9 KB
Toggle Summary Feb 16, 2010	EDAP Reports Record Full Year 2009 Preliminary Unaudited Results 2009 Highlights: , Feb 16, 2010 (GlobeNewswire via COMTEX News Network) -- Record revenue of EUR 24.9 million (USD 34.7 million), up 7.9% year-over-year -- Ablatherm-HIFU RPP treatments increased 24.0% year-over-year -- Strong EUR 12.7 million (USD 18.2 million) cash position LYON, France, Feb.	View HTML EDAP Reports Record Full Year 2009 Preliminary Unaudited Results 14.4 KB
Toggle Summary Feb 02, 2010	EDAP Reports on FDA Meeting LYON, France, Feb 2, 2010 (GlobeNewswire via COMTEX News Network) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, announced that the FDA at its meeting on January 28, 2010 confirmed the recommendations of the Gastroenterology and Urology Devices Panel of the Medical	View HTML EDAP Reports on FDA Meeting 14.2 KB